LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, today announced it has partnered with BioLabs and E25Bio to launch the Cambridge Consortium for Rapid COVID-19 Tests (CCRCT). The goal of this new testing initiative is to combine resources and validate fast, affordable diagnostic assays to provide SARS-CoV-2 screening for asymptomatic populations as part of a strategy for safely returning to work, school or other aspects of daily life.